ロード中...
Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels
BACKGROUND: The drug-resistance and relapse of diffuse large B-cell lymphoma (DLBCL), which are related to mesenchymal stem cells (MSCs), have become increasingly common. However, the underlying mechanisms remain elusive. METHODS: CCK 8 assay, colony formation assay, and xenograft mouse model were u...
保存先:
| 出版年: | J Exp Clin Cancer Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6373150/ https://ncbi.nlm.nih.gov/pubmed/30755239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1081-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|